- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PHARMASIMPLE Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INNOCAN PHARMA | 1,380 | -18,34 % | InnoCan Pharma vor kritischer Marke: Was die wenigsten Anleger auf dem Schirm haben - Was ich konkret unternommen habe! | ||
| SYNBIOTIC | 1,118 | +1,64 % | SYNBIOTIC SE: Portfoliobereinigung setzt die Basis neu; Kursziel gesenkt, bleibt jedoch Spek. KAUFEN | SYNBIOTIC stellt sein Portfolio neu auf, nachdem Hempro International, HANF FARM und Hemp Factory in Richtung Liquidation und/oder Insolvenz gehen, bedingt durch einen starken Rückgang der Nachfrage... ► Artikel lesen | |
| BIONANO GENOMICS | 1,175 | +3,07 % | Bionano Genomics: Bionano Announces Hiring of Chief Scientific Officer | SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific... ► Artikel lesen | |
| AXSOME THERAPEUTICS | 207,80 | -2,21 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) | NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today... ► Artikel lesen | |
| JAGUAR HEALTH | 2,960 | -1,66 % | Jaguar Health, Inc.: Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend | Company remains sharply focused on its ongoing global development program for crofelemer for rare intestinal failure diseasesReminder: Two crofelemer presentations in pediatric intestinal failure patients... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,005 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| TRULIEVE CANNABIS | 8,120 | +4,77 % | Canopy, Tilray & Co. zittern: Lässt die DEA Cannabis-Aktien beben? Darauf sollten Anleger ab Montag achten | © Foto: adobe.stock.comJetzt gilt es für den Cannabis-Sektor: Am Montag startet das Anhörungsverfahren der DEA - für viele Unternehmen geht es dabei um alles.Cannabis - Seit April fährt die DEA zweigleisig... ► Artikel lesen | |
| WEST PHARMACEUTICAL SERVICES | 306,80 | -0,39 % | West Pharmaceutical Services, Inc.: West Appoints Michel Lagarde to be President and Chief Executive Officer | Experienced healthcare and life sciences executive to lead the Company's next phase of growth and innovation EXTON, Pa., June 1, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc.... ► Artikel lesen | |
| SHIONOGI | 15,250 | +1,09 % | Shionogi & Co., Ltd. Profit Climbs In Full Year | TOKYO (dpa-AFX) - Shionogi & Co., Ltd. (SGIOF) revealed earnings for its full year that Increased, from last yearThe company's bottom line totaled JPY205.159 billion, or JPY241.04 per share.... ► Artikel lesen | |
| KALA BIO | 2,100 | -16,67 % | XFRA 27F: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILKALA BIO INC. O.N.... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,251 | +0,92 % | Theriva Biologics, Inc.: Theriva Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research | - Prolonged overall survival (OS) was observed in heavily pre-treated refractory Head & Neck Squamous Cell Carcinoma (HNSCC) patients administered IV VCN-01 prior to the immune checkpoint inhibitor... ► Artikel lesen | |
| CHARLOTTES WEB | 0,290 | 0,00 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Provides Update on Diverging Hemp Policies: Federal Momentum Builds as California Restricts Therapeutic Hemp Product Access | Louisville, Colorado--(Newsfile Corp. - June 26, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and... ► Artikel lesen | |
| NRX PHARMACEUTICALS | 3,500 | +7,03 % | NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute | WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx" or the "Company") today issued the following statement in response to recent public claims made... ► Artikel lesen | |
| BEXIMCO PHARMACEUTICALS | 0,450 | -25,00 % | AIM - Restoration - Beximco Pharmaceuticals PLC | ||
| THERAPEUTICSMD | 1,890 | +6,18 % | TherapeuticsMD, Inc. - 8-K, Current Report |
PHARMASIMPLE SA gehört der Branche Pharma an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMASIMPLE SA finden Sie auf Wallstreet Online.